LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease

Summary

The purpose of this study is to evaluate the efficacy of LME636 compared to vehicle in the reduction of ocular symptoms and to evaluate the safety and tolerability of LME636, when administered topically for up to 42 days, in subjects with severe dry eye disease.

Timeline

Start

2015-03-09

Primary completion

2015-10-16

Completion

2015-10-16

Drugs

Indications